Optimising biological activity and ADME properties, while minimising toxicity, are objectives when developing new compounds. Advanced machine learning methods are indispensable to this process. The AiChemist project will develop and benchmark representation learning approaches, addressing their accuracy and explainability, using public and in-house data for various endpoints. Follow us on LinkedIn and BlueSky!